The ASXL1 gene alterations in patients with 20q deletion

被引：0
|
作者：
Brezinova, Jana [1 ]
Sarova, Iveta [1 ]
Lhotska, Halka [2 ,3 ]
Ransdorfova, Sarka [1 ]
Izakova, Silvia [2 ,3 ]
Svobodova, Karla [2 ,3 ]
Markova, Jana [4 ]
Zemanova, Zuzana [2 ,3 ]
Cermak, Jaroslav [5 ]
Jonasova, Anna [6 ,7 ]
Michalova, Kyra [2 ,3 ]
机构：
[1] Inst Hematol & Blood Transfus, Dept Cytogenet, Prague, Czech Republic
[2] ULBLD, Gen Univ Hosp, Prague, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Ctr Oncocytogenet, Prague, Czech Republic
[4] Inst Hematol & Blood Transfus, Dept Mol Genet, Prague, Czech Republic
[5] Inst Hematol & Blood Transfus, Clin Dept, Prague, Czech Republic
[6] Gen Univ Hosp, Prague, Czech Republic
[7] Charles Univ Prague, Fac Med 1, Dept Med 1, Prague, Czech Republic
来源：
CHROMOSOME RESEARCH | 2015年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2.P12
引用
收藏
页码：S80 / S81
页数：2
相关论文
共 50 条
  • [1] ASXL1 gene alterations in patients with isolated 20q deletion
    Brezinova, J.
    Sarova, I.
    Svobodova, K.
    Lhotska, H.
    Ransdorfova, S.
    Izakova, S.
    Pavlistova, L.
    Lizcova, L.
    Skipalova, K.
    Hodanova, L.
    Markova, J.
    Zemanova, Z.
    Cermak, J.
    Jonasova, A.
    Michalova, K.
    NEOPLASMA, 2019, 66 (04) : 627 - 630
  • [2] Molecular cytogenetic detection of the ASXL1 gene alterations in patients with 20q deletion
    Brezinova, Jana
    Sarova, Iveta
    Ransdorfova, Sarka
    Svobodova, Karla
    Lhotska, Halka
    Izakova, Silvia
    Pavlistova, Lenka
    Zemanova, Zuzana
    Markova, Jana
    Cermak, Jaroslav
    Jonasova, Anna
    Michalova, Kyra
    MOLECULAR CYTOGENETICS, 2017, 10
  • [3] The ASXL1 Gene Alterations in Patients with Myeloid Diseases and Chromosomal 20q Deletion
    Brezinova, Jana
    Sarova, Iveta
    Lhotska, Halka
    Ransdorfova, Sarka
    Izakova, Silvia
    Svobodova, Karla
    Markova, Jana
    Zemanova, Zuzana
    Cermak, Jaroslav
    Jonasova, Anna T.
    Michalova, Kyra
    BLOOD, 2014, 124 (21)
  • [4] Impact of ASXL1 Gene Alterations on Myelodysplastic Syndrome With Isolated 20q Deletion
    Chang, Yanan
    Liu, Linlin
    Cui, Chenghua
    He, Jiange
    Li, Chengwen
    Jia, Yujiao
    Zhang, Ruixue
    Wu, Wanyun
    Zhou, Ji
    Xiao, Jigang
    Xu, Zefeng
    Qin, Tiejun
    Sun, Qi
    Wang, Huijun
    Xiao, Zhijian
    CANCER MEDICINE, 2025, 14 (05):
  • [5] THE ASXL1 GENE ALTERATIONS IN BONE MARROW CELLS OF PATIENTS WITH DELETION 20Q AND MYELOID DISORDERS
    Brezinova, J.
    Sarova, I.
    Lhotska, H.
    Ransdorfova, S.
    Izakova, S.
    Svobodova, K.
    Podskalska, L.
    Markova, J.
    Zemanova, Z.
    Cermak, J.
    Jonasova, A.
    Michalova, K.
    HAEMATOLOGICA, 2016, 101 : 767 - 768
  • [6] MYELODYSPLASTIC SYNDROMES WITH 20Q DELETION: INCIDENCE, PROGNOSTIC VALUE AND THERAPEUTIC IMPACT OF CHROMOSOMAL ALTERATIONS OF THE ASXL1 GENE AND GENETIC MUTATIONS
    Martin, Castillo, I
    Villamon, Ribate E.
    Abellan, Sanchez R.
    Calasanz, Abinzano M. J.
    Irigoyen, Barranco A.
    Such, Taboada E.
    Mora, Castera E.
    Gutierrez, Serrano M.
    Collado, Nieto R.
    Vara, Pampliega M.
    Blanco, M. L.
    Oiartzabal, Ormategi, I
    Alvarez, De Andres S.
    Bernal, Del Castillo T.
    Granada, Font, I
    Xicoy, Cirici B.
    Jerez, Cayuela A.
    Fernandez, Gonzalez R.
    Tormo, Diaz M.
    HAEMATOLOGICA, 2020, 105 : 70 - 70
  • [7] Myelodysplastic Syndromes with 20q Deletion: Incidence, Prognostic Value and Impact on Response to Azacitidine of ASXL1 Chromosomal Deletion and Genetic Mutations
    Martin, Ivan
    Villamon, Eva
    Abellan, Rosario
    Calasanz, Maria Jose
    Irigoyen, Aroa
    Sanz, Guillermo F.
    Such, Esperanza
    Castera, Elvira Mora
    Gutierrez, Miriam
    Collado, Rosa
    Vara, Miriam
    Blanco, Laura
    Oiartzabal, Itziar
    Alvarez, Sara
    del Castillo, Teresa Bernal
    Granada, Isabel
    Xicoy, Blanca
    Zamora, Lurdes
    Jerez, Andres
    Fernandez, Raquel
    Calabuig, Marisa
    Garcia, Francisca
    Sanz, Alejandro
    Diez, Rosana
    Gil, Angela
    de Paz, Raquel
    Lopez, Francisca
    Gonzalez, Teresa
    Solano, Carlos
    Tormo, Mar
    BLOOD, 2020, 136
  • [8] Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations
    Martin, Ivan
    Villamon, Eva
    Abellan, Rosario
    Calasanz, Maria Jose
    Irigoyen, Aroa
    Sanz, Guillermo
    Such, Esperanza
    Mora, Elvira
    Gutierrez, Miriam
    Collado, Rosa
    Garcia-Serra, Rocio
    Vara, Miriam
    Blanco, Ma Laura
    Oiartzabal, Itziar
    alvarez, Sara
    Bernal, Teresa
    Granada, Isabel
    Xicoy, Blanca
    Jerez, Andres
    Calabuig, Marisa
    Diez, Rosana
    Gil, Angela
    Diez-Campelo, Maria
    Solano, Carlos
    Tormo, Mar
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (04) : 708 - 717
  • [9] Myelodysplastic Syndromes (MDS) with 20q Deletion frequently show mutations in U2AF1, SRSF2 and ASXL1
    Bacher, U.
    Haferlach, T.
    Schnittger, S.
    Zenger, M.
    Grossmann, V
    Roller, A.
    Meggendorfer, M.
    Jeromin, S.
    Krauth, M-T
    Alpermann, T.
    Kern, W.
    Haferlach, C.
    ONKOLOGIE, 2013, 36 : 125 - 125
  • [10] Conditional Deletion of Asxl1 Results in Myelodysplasia
    Abdel-Wahab, Omar
    Gao, Jie
    Adli, Mazhar
    Chung, Young Rock
    Koche, Richard
    Shih, Alan H.
    Pandey, Suveg
    La-Fave, Lindsay M.
    Ndiaye-Lobry, Delphine
    Shin, Yu Sup
    Bhatt, Parva K.
    Patel, Jay P.
    Zhao, Xinyang
    Park, Christopher Y.
    Jaffe, Jacob D.
    Bernstein, Bradley E.
    Aifantis, Iannis
    Levine, Ross L.
    BLOOD, 2012, 120 (21)
12345